Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis

Published:2021-02-08 Issue:5 Volume:60 Page:2855-2875
ISSN:1436-6207
Container-title:European Journal of Nutrition
language:en
Short-container-title:Eur J Nutr

Author:

Zhang Xiao-Feng^ORCID,Guan Xiao-Xian^ORCID,Tang Yu-Jun^ORCID,Sun Jin-Feng^ORCID,Wang Xiao-Kai^ORCID,Wang Wei-Dong^ORCID,Fan Jian-Ming^ORCID

Funder

National Natural Science Foundation of China

Science and Technology Department of Henan Province

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://link.springer.com/content/pdf/10.1007/s00394-021-02503-5.pdf

Reference75 articles.

1. Jairath V, Feagan BG (2020) Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol 5(1):2–3. https://doi.org/10.1016/s2468-1253(19)30358-9

2. Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon MR, Abdoli A, Abolhassani H, Alipour V, Almadi MAH, Almasi-Hashiani A, Anushiravani A, Arabloo J, Atique S, Awasthi A, Badawi A, Baig AAA, Bhala N, Bijani A, Biondi A, Borzì AM, Burke KE, Carvalho F, Daryani A, Dubey M, Eftekhari A, Fernandes E, Fernandes JC, Fischer F, Haj-Mirzaian A, Haj-Mirzaian A, Hasanzadeh A, Hashemian M, Hay SI, Hoang CL, Househ M, Ilesanmi OS, Jafari Balalami N, James SL, Kengne AP, Malekzadeh MM, Merat S, Meretoja TJ, Mestrovic T, Mirrakhimov EM, Mirzaei H, Mohammad KA, Mokdad AH, Monasta L, Negoi I, Nguyen TH, Nguyen CT, Pourshams A, Poustchi H, Rabiee M, Rabiee N, Ramezanzadeh K, Rawaf DL, Rawaf S, Rezaei N, Robinson SR, Ronfani L, Saxena S, Sepehrimanesh M, Shaikh MA, Sharafi Z, Sharif M, Siabani S, Sima AR, Singh JA, Soheili A, Sotoudehmanesh R, Suleria HAR, Tesfay BE, Tran B, Tsoi D, Vacante M, Wondmieneh AB, Zarghi A, Zhang Z-J, Dirac M, Malekzadeh R, Naghavi M (2020) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5(1):17–30. https://doi.org/10.1016/s2468-1253(19)30333-4

3. Kaplan GG (2015) The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 12(12):720–727. https://doi.org/10.1038/nrgastro.2015.150

4. Mak WY, Zhao M, Ng SC, Burisch J (2020) The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol 35(3):380–389. https://doi.org/10.1111/jgh.14872

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging role of the gut microbiota and its application in inflammatory bowel disease;Biomedicine & Pharmacotherapy;2024-10

2. Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin;PLOS Pathogens;2024-09-09

3. Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks;Current Medicinal Chemistry;2024-09

4. Comment on “Environmental factors and their impact on chronic pain development and maintenance.”;Physics of Life Reviews;2024-09

5. The Microbiome in Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-07